Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 651-660 of 1760 for

Edit search filters
  1. Evaluation Of T-RFA And RF-TVA Prior To/Following Radiation Therapy To Treat Painful Metastatic Vertebral Body Tumor(s)

    Rochester, MN

  2. Focal Laser Ablation Of Prostate Cancer Tumors

    Rochester, MN

  3. Veliparib With Carboplatin And Paclitaxel And As Continuation Maintenance Therapy In Subjects With Newly Diagnosed Stage III Or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

    Rochester, MN

  4. A Study Of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) In Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel In Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130)

    Scottsdale/Phoenix, AZ

  5. A Study Of X4P-001 In Patients With Advanced Renal Cell Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. A Phase 2 Study Of CPI-0610 With And Without Ruxolitinib In Patients With Myelofibrosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Study Of DCC-3014 In Patients With Advanced Tumors And Tenosynovial Giant Cell Tumor

    Jacksonville, FL, Rochester, MN

  8. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

    Rochester, MN

  9. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Imiquimod And Pembrolizumab In Treating Patients With Stage IIIB-IV Melanoma

    Jacksonville, FL

.

Mayo Clinic Footer